US 2006/0052333 A1 · Method of treating arrhythmias

Abstract

Methods are provided for treating arrhythmia in a manner that minimizes undesirable side effects, comprising administration of a therapeutically effective minimal dose of an Al adenosine receptor agonist with a therapeutically effective minimal dose of a beta blocker, calcium channel blocker, or a cardiac glycoside.

Claims19

Dependent claims

1-18. (canceled)

Dependencies are inferred from the claim text.

Facts

Application

11/262,025Filed 28 Oct 2005

Priority

18 Apr 2002

Published

9 Mar 2006

Term ends

Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 31/137
Having aromatic rings , e.g. ketamine, nortriptyline: arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
A61K 31/138
Having aromatic rings , e.g. ketamine, nortriptyline: aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K 31/44
Having six-membered rings with one nitrogen as the only ring hetero atom: non condensed pyridines; Hydrogenated derivatives thereof

Family

Application60/373,766Us provisional application · filed 18 Apr 2002

Application10/418,654Division · filed 18 Apr 2003

Application11/262,025Division · filed 28 Oct 2005

US 2003/0216349 A1Published application

US 7,005,425 B2Related patent

US 7,479,485 B2Related patent

US 2006/0052333 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

11/262,025Filed 28 Oct 2005

Priority

18 Apr 2002

Published

9 Mar 2006

Term ends

Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 31/137
Having aromatic rings , e.g. ketamine, nortriptyline: arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
A61K 31/138
Having aromatic rings , e.g. ketamine, nortriptyline: aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K 31/44
Having six-membered rings with one nitrogen as the only ring hetero atom: non condensed pyridines; Hydrogenated derivatives thereof

Family

Application60/373,766Us provisional application · filed 18 Apr 2002

Application10/418,654Division · filed 18 Apr 2003

Application11/262,025Division · filed 28 Oct 2005

US 2003/0216349 A1Published application

US 7,005,425 B2Related patent

US 7,479,485 B2Related patent

US 2006/0052333 A1This patent

From the US filing history. Foreign family members aren’t listed.

Method of treating arrhythmias

Life of this patent

Abstract

Claims19

Method of treating arrhythmias

Life of this patent

Abstract

Claims19